2003
DOI: 10.1590/s0066-782x2003000300009
|View full text |Cite
|
Sign up to set email alerts
|

Symptomatic myocardial bridging or cardiac Whipple's Diseas

Abstract: patient suffered from progressive dyspnea, palpitations, and precordial pain. In fact, he was admitted to the hospital with a diagnosis of coronary disease and atrial flutter. Serum cardiac enzymes and routine laboratory tests were considered normal, except for mild, microcytic anemia. He underwent electrical cardioversion, and amiodarone was started. Echocardiography revealed mild antero-lateral wall hypokinesis, a moderate left ventricular dilatation with preserved ejection fraction, thickening of the mitral… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…[6] The cholesterol-reducing properties of PS were generally thought of as competitive inhibition of cholesterol intestinal absorption and the PSinduced modulation of genes involved in cholesterol metabolism. [7,8] However, the conclusion that PS reduces the risk of cardiovascular disease could not be drawn, because some studies suggest an increased risk of atherosclerosis with high levels of PS in plasma, [9,10] which indicates a complex role of PS in atherosclerosis development besides its cholesterol-lowering effects.…”
Section: Introductionmentioning
confidence: 99%
“…[6] The cholesterol-reducing properties of PS were generally thought of as competitive inhibition of cholesterol intestinal absorption and the PSinduced modulation of genes involved in cholesterol metabolism. [7,8] However, the conclusion that PS reduces the risk of cardiovascular disease could not be drawn, because some studies suggest an increased risk of atherosclerosis with high levels of PS in plasma, [9,10] which indicates a complex role of PS in atherosclerosis development besides its cholesterol-lowering effects.…”
Section: Introductionmentioning
confidence: 99%
“…[ 12 ] High phytosterol intake (2 g day −1 ) can lead to a significant reduction of LDL‐cholesterol. [ 11 ] A typical Western diet contains only about 300 mg day −1 of phytosterols. Foods enriched with phytosterols, phytosterol supplements, and phytostanols are used to lower cholesterol.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, they compete with cholesterol at the site of intestinal absorption of cholesterol. [9,11] In addition, phytosterols may regulate cholesterol biosynthesis in enterocytes and hepatocytes. [12] High phytosterol intake (2 g day −1 ) can lead to a significant reduction of LDL-cholesterol.…”
Section: Introductionmentioning
confidence: 99%